Intravenous immunoglobulin (IVIG) is one of many treatment options being used to treat children with Multisystem Inflammatory Syndrome in Children (MIS-C). Given concerns about the supply availability of IVIG, GNYHA will host a webinar on Thursday (June 4) from 2:00 p.m. to 3:00 p.m.
The webinar will discuss the pre-COVID-19 and current supply landscape for IVIG, and review the existing structures used to manage the IVIG supply. Featured speakers include:
- Kim Elmore, Senior Director, Pharmacy Contracting, Premier Inc.
- Patrick Schmidt, Chief Executive Officer, FFF Enterprises
- Sudha Narayanaswamy, Vice President, Pharmacy Practice, Acurity Inc.
Pediatric providers and others involved in the care of patients with MIS-C, pharmacy directors, and emergency managers are the target audience for this webinar.